MetaCap

Nanobiotix S.A. (NBTX) vs uniQure N.V. (QURE)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Nanobiotix S.A. (NBTX) has outperformed uniQure N.V. (QURE) over the past year, gaining 26.6% versus a loss of 30.4%. Over five years, NBTX leads with a +214.0% price change compared with -32.9% for QURE. uniQure N.V. is the larger company by market cap ($1.36 billion vs $1.35 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NBTX+26.61%QURE-30.42%
+175%+48%-79%
Nov 21, 20251 yearNov 20, 2026
NBTX+185.87%QURE-34.72%
+483%+184%-114%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NBTX versus QURE key metrics
MetricNBTXQURE
Share price$26.50$19.35
Market cap$1.35B$1.36B
1-day change-2.98%-4.35%
YTD return+14.62%-19.14%
1-year return+26.61%-30.42%
5-year return+213.98%-32.86%
EPS (TTM)$-1.27$-3.51
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$16.10M
Revenue growth (YoY)—-40.64%
Net income (latest FY)—$-198.97M
Gross margin—89.53%
Operating margin—-1151.38%
Net margin—-1236.00%
52-week high$57.14$51.72
52-week low$19.14$8.73
Distance from 52-week high-53.62%-62.59%
Analyst consensusnonestrong_buy
Avg. price target upside+101.06%+207.03%
Average volume148.94K2.26M
Shares outstanding50.95M70.14M
Employees98221
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • NBTX has outperformed QURE by 57.0 percentage points over the past year.

About Nanobiotix S.A.

NBTX stock →

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs.

Health Care · Biotechnology: Pharmaceutical Preparations · 98 employees

About uniQure N.V.

QURE stock →

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 221 employees

NBTX vs QURE FAQ

Which is bigger, Nanobiotix S.A. or uniQure N.V.?

uniQure N.V. (QURE) is larger, with a market capitalization of $1.36B compared with $1.35B for Nanobiotix S.A. (NBTX).

Which stock has performed better over the past year, NBTX or QURE?

NBTX returned +26.61% over the past 12 months, compared with -30.42% for QURE (price return, excluding dividends). Past performance does not predict future results.

Are Nanobiotix S.A. and uniQure N.V. in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons